Citation: | CHEN Shumin, HUANG Wenlong, HU Guoqiang. Synthesis and antitumor activity of fluoroquinolone C-3 isostere V: ciprofloxacin acylhydrazone derivatives[J]. Journal of China Pharmaceutical University, 2014, 45(2): 161-164. DOI: 10.11665/j.issn.1000-5048.20140205 |
[1] |
Dong,KC,Berger JM.Structural basis for gate-DNA recognition and bending by type IIA topoisomerases[J].Nature,2007,450(7 173):1 201-1 205.
|
[2] |
Al-Trawneh SA,Zahra JA,Kamal MR,et al.Synthesis and biological evaluation of tetracyclic fluoroquinolones as antibacterial and anticancer agents[J].Bioorg Med Chem,2010,18(16):5 873-5 884.
|
[3] |
Xu QJ,Hou LL,Wu ZF,et al.Synthesis and antitumor activity of fluoroquinolone C-3 isostere III:s-triazole oxadiazole methylsulfide derivatives from pefloxacin[J].J China Pharm Univ(中国药科大学学报),2013,44(6):511-514.
|
[4] |
Hu GQ, Zhang ZQ, Wang HY, et al. Synthesis and antitumor activity of fluoroquinolon -3-yl fused heterocyclic systems(III):s-triazolothiadiazinone derivatives derived enrofoxacin[J].Acta Chim Sinica(化学学报),2009,67(22):2 592-2 596.
|
[5] |
Guo ZR,Zhao HY.Challenges and strategies of drug innovation[J].Acta Pharm Sin(药学学报),2013,48(7):1 031-1 040.
|
[6] |
Zhang B,Zhao Y,Zhai X,et al.Design,synthesis and anticancer activities of diaryl urea derivatives bearing N-acylhydrazone moiety[J].Chem Pharm Bull(Tokyo),2012,60(8):1 046-1 054.
|
[7] |
Xu QJ,Hou LL,Wu XK,et al.Synthesis and antitumor activity of ciprofloxacin bis-(C3/C7 hydrazone)s[J].J China Pharm Univ(中国药科大学学报),2013,44(1):35-38.
|
[8] |
Xie SQ,Chen YS,Wang GQ,et al.Part IV.Synthesis and antitumor evaluation of s-triazolothiadiazines and pyrazolo s-triazoles derived from ciprofloxacin[J].Acta Pharm Sin(药学学报),2012,47(1):66-71.
|